Myriad Genetics' Q2 Revenues Rise 11 Percent; Profit up 67 Percent

Myraid's sales for the quarter jumped sharply, with the company citing its sales force expansion as a primary driver of revenue gains.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.